[ad_1]
Featured news from Health
Two nurses (one in Mexico and one in Chile) are the first people to receive the vaccine from Pfizer and BioNTech in the south of the American continent. They would arrive in Colombia in February.
Just before Christmas Day, two planes loaded with 10,000 vaccines landed on Latin American soil. One arrived in Mexico City and the other in Santiago de Chile.
The specialist nurse María Irene Ramírez, 59 years old and head of Nursing of the Intensive Care Unit of the Rubén Leñero Hospital in Mexico City today became the first person to receive the Pfizer-BioNTech vaccine in that country.
As for Chile, the first person to receive the vaccine was Zulema Riquelme, a senior nursing technician. “It was something unexpected. I’m excited. That all the people get vaccinated and keep getting vaccinated ”, declared Riquelme. And he added: “” I understand that people are suspicious because it is good, but that they get vaccinated as soon as possible and that they take good care of themselves, which is what we who work in health say the most. They help us lower our workload, ”according to the Chilean newspaper La Tercera.
Both countries bought the vaccine from Pfizer and BioNTech, whose first clinical trials showed 95% effectiveness. As in Colombia, Chile and Mexico gave priority to health personnel and people over 60 years of age to receive the vaccine before the bulk of the population. A plane with another 10,000 doses of the Russian Sputnik vaccine also arrived in Argentina today. (Guide to Navigating the Sea of Vaccine Information)
In Colombia it was announced last week that the vaccine is expected to begin in the first half of 2021. Faced with the first question of when can the first doses be applied? In the case of Colombia, Minister Fernando Ruiz said that they hope to be able to start applying vaccines against the virus in the first half of 2021. Doses that will surely have to come from the independent purchase that the Colombian government agrees with the producing pharmaceutical companies, because the help of plans such as COVAX, an international alliance to ensure the Equity in access, with which it was expected to vaccinate 10 million people, will arrive only until the second half of 2021. (In context: This is what you need to know to understand the world of vaccines)
As soon as the vaccine arrives in the country, the first doses will be reserved for the groups with the highest risk of mortality: health workers (800,000 people), over 60 years (6.8 million people), and the population with comorbidities such as hypertension , diabetes, heart disease and kidney deficiencies (6.4 million people).
The giant Pfizer and BioNTech assured that their product would be 95% effective, the Moderna laboratory reported that their immunizer would have registered an effectiveness rate of 94% and the bet of the University of Oxford and AstraZeneca would show 70.4%.
